Clinical Trials Logo

Ocular Graft vs Host Disease clinical trials

View clinical trials related to Ocular Graft vs Host Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT03591874 Terminated - Clinical trials for Graft Versus Host Disease

Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease

oGVHD
Start date: December 23, 2018
Phase: Phase 3
Study type: Interventional

This study evaluates the use of Brimonidine tartrate nanoemulsion eye drop solution in the treatment of ocular Graft Verses Host Disease (oGVHD). Two thirds of participants will receive Brimonidine and one third will receive ophthalmic buffered saline (placebo).

NCT ID: NCT02975557 Terminated - Dry Eye Clinical Trials

Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to establish whether patients with dry eye disease (DED) are able to tolerate receiving Brimonidine: 0.15% eye drops two times a day for twelve weeks (primary tolerability objective) and to investigate the preliminary efficacy of Brimonidine 0.15% topical eye drop solution in treating Meibomian Gland Dysfunction (MGD) (primary efficacy objective). Meibomian Gland dysfunction can happen with numerous conditions such as Rosacea, Sjögren's syndrome, and oGVHD. In order to limit the influence of differing etiologies on the outcome of this trial, the investigator has limited the screening to MGD that accompanies oGVHD.

NCT ID: NCT02702518 Terminated - Dry Eye Clinical Trials

rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

Start date: April 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the tolerability and preliminary efficacy of rhDNase I eye drops in patients with ocular Graft-vs.-Host disease (oGVHD).